NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

research on ivermectin looks promising. Overall death rate dropped from 8.5% to 1.4%.

Results: The cohort (including 704 treated and 704 controls) derived from 169 hospitals across 3 continents with COVID-19 illness. The patients were matched for age, sex, race or ethnicity, comorbidities and a illness severity score (qSOFA). Of those requiring mechanical ventilation fewer patients died in the ivermectin group (7.3% versus 21.3%) and overall death rates were lower with ivermectin (1.4% versus 8.5%; HR 0.20 CI 95% 0.11-0.37, p<0.0001).

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3580524

Interesting that mainstream sources are ignoring it. Seems worth a mention.